View all cases
UPC CFI 1707/2025
Jul 3, 2025·EP4226941 +1 more · PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA
- Case details
- StatusInterim PhaseActionCounterclaim for revocationCategoryCounterclaim for revocation
- Parties
- Claimants
- C.P. Pharmaceuticals International C.V.Operating co.
- Pfizer Export B.V.Operating co.
- Pfizer B.V.Operating co.
- Pfizer Manufacturing Belgium NVOperating co.
- Pfizer Service Company S.R.L.Operating co.
- Pfizer S.A.Operating co.
- Pfizer Luxembourg SARLOperating co.
- Pfizer Inc.Operating co.
- Pfizer Corporation Austria GmbHOperating co.
- Pfizer ApSOperating co.
- Pfizer OyOperating co.
- Pfizer SASOperating co.
- Pfizer Pharma GmbHOperating co.
- Pfizer S.r.l.Operating co.
- Laboratórios Pfizer, Lda.Operating co.
- Pfizer Romania S.R.L.Operating co.
- Pfizer ABOperating co.
- Pfizer, spol. S.r.o.Operating co.
- Pfizer Hellas A.E.Operating co.
- Pfizer, S.L.Operating co.
- Pfizer Croatia d.o.o.Operating co.
- Pfizer Gyógyszerkereskedelmi Kft.Operating co.
- Pfizer Polska Sp. Z.o.o.Operating co.
- Pfizer Trading Polska Sp. Z.o.o.Operating co.
- Pfizer AGOperating co.
- Pfizer ASOperating co.
- BioNTech SEOperating co.
- BioNTech Europe GmbHOperating co.
- BioNTech Manufacturing GmbHOperating co.
- BioNTech Manufacturing Marburg GmbHOperating co.
Representatives- Christian Dekoninck-Taylor Wessing
- Joel Coles-Powell Gilbert (Europe) LLP
Respondents- GlaxoSmithKline Biologicals SAOperating co.
Representatives- Carlos van Staveren-Bird & Bird LLP
- Division
- The Hague LD
- Technology
- ChemistryPharmaceuticals
- Language
- English
- EPO Opposition
- Thomann, WilliamAdmissible2023-09-06
- SANOFIAdmissible2023-09-06
- Weickmann & Weickmann PartmbBAdmissible2023-09-07
- JG Oppositions LimitedAdmissible2023-09-07
- ModernaTX, Inc.Admissible2025-07-15
- SANOFIAdmissible2025-07-22
- Weickmann & Weickmann Patent- und Rechtsanwälte PartmbBAdmissible2025-07-22
- BioNTech SEAdmissible2025-07-22
- Arrowhouse GmbHAdmissible2025-07-23
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
| Patent revoked | Median days to first decision | |
|---|---|---|
| All UPC | 37% (34/91) | 124 |
| The Hague LD | Locked | Locked |
| Judge Edger Brinkman | Locked | Locked |
| Judge Margot Kokke | Locked | Locked |
| Judge Stefan Schilling | Locked | Locked |
| Judge Martin Schmidt | Locked | Locked |
At the UPC: Pfizer Group (31 cases)·GlaxoSmithKline Biologicals SA (20 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
This dispute contains 2 other proceedings
3 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: The Hague LD·2025
Documents
Show all 388 documents| Document title | Date | Public |
|---|---|---|
| Receipt | 2026-10-05 | Not public |
| Cover sheet | 2026-10-05 | Not public |
| Submission Defendant | 2026-10-05 | Not public |
| Exhibit Defendant | 2026-10-05 | Not public |
| Exhibit Defendant | 2026-10-05 | Not public |
| Exhibit Defendant | 2026-10-05 | Not public |
| Receipt | 2026-10-05 | Not public |
| Cover sheet | 2026-10-05 | Not public |
| Document | 2026-10-05 | Not public |
| Document | 2026-10-05 | Not public |